Cigarette Smoking in Smokers With and Without Schizophrenia

Schizophrenia Clinical Trial

Official title:

Cigarette Smoking in Smokers With and Without a Diagnosis of Schizophrenia

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04001114
• Other study ID #: HP-00086422
• Status: Recruiting
• Phase: N/A
• Start date: July 15, 2021
• Est. completion date: December 2023

Study information

• Verified date: October 2022
• Source: University of Maryland, Baltimore
• Contact: Britta Hahn, Ph.D.
• Phone: 4104026112
• Email: bhahn[@]som.umaryland.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Higher rates and severity of tobacco dependence in people with schizophrenia, as compared with the general population, contribute to the lower life expectancy seen in this population. Dependent tobacco smoking is controlled by how different aspects of cigarette smoking are perceived. There is evidence suggesting that people with schizophrenia differ in how they perceive cigarette smoking, which, if confirmed, would have implications for tailoring treatment interventions for smoking cessation in schizophrenia.

Description:

The aim of the present study is to determine whether tobacco smoking in people with schizophrenia is governed by different aspects and effects of cigarette consumption. Smokers participating in this study either have no psychiatric diagnosis, or a diagnosis of schizophrenia or schizoaffective disorder. Over four study visits, participants will sample and compare different research cigarettes, complete questionnaires and concentration tasks, and smoke one type of research cigarette for eight hours while wearing a nicotine patch. By shaping our understanding of tobacco dependence in schizophrenia, the present project may redirect treatment development toward strategies tailored to the specific vulnerabilities of this population, which is among the most severely affected by its detrimental impact on health and life.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 90
• Est. completion date: December 2023
• Est. primary completion date: June 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Regular smoker of at least 10 cigarettes or cigarillos/day for at least 2 years

• For participants with schizophrenia: DSM-5 diagnosis of schizophrenia or schizoaffective disorder

• For participants with schizophrenia: Able to give informed consent

• For smokers with schizophrenia: No change in psychiatric medication or dosage in the last 4 weeks

Exclusion Criteria:

• Uncontrolled hypertension (resting systolic BP above 150 or diastolic above 95 mm Hg)

• Cardiovascular disease, such as history of myocardial infarction and ischemia, heart failure, angina, severe arrhythmias, or EKG abnormalities

• Severe asthma

• Chronic obstructive pulmonary disease

• Neurological illness, such as stroke, seizure disorder, neurodegenerative disease, or organic brain syndrome

• Mental retardation

• Alcohol or substance use disorder except nicotine within the last year

• Use of benztropine (Cogentin), varenicline (Chantix), bupropion (Wellbutrin, Zyban), or any type of nicotine replacement

• Pregnant or lactating

• For healthy control smokers: DSM-5 diagnosis of depression, bipolar disorder, ADHD, autism spectrum disorder, anorexia, bulimia nervosa, or any schizophrenia-spectrum disorder

• For healthy control smokers: immediate family history of psychosis

Related Conditions & MeSH terms

• Schizophrenia
• Tobacco Dependence
• Tobacco Use Disorder

Intervention

Combination Product:
• Sampling Research Cigarettes
Participants sample two research cigarettes, which differ in typical tobacco smoke constituents such as tar, nicotine, carbon monoxide, etc. In the Cigarette Discrimination Session, participants sample both types of cigarettes repeatedly, guess their identity (A or B) with regard to reference cigarettes, and rate their subjective effects. In the Ad Libitum Smoking Session, participants can smoke one of these cigarette types as much or as little as they like for eight hours.

Locations

Country	Name	City	State
United States	Maryland Psychiatric Research Center	Catonsville	Maryland

Sponsors (1)

Lead Sponsor	Collaborator
University of Maryland, Baltimore

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in exhaled carbon monoxide	The concentration (ppm) of carbon monoxide (CO) in breath is measured by exhalation into a CO breathalyzer at the beginning of the Ad Libitum Smoking Session (baseline), and at the end eight hours later. The change value is obtained by subtracting each participant's baseline value from the end-of-session value.	One day (in the Ad Libitum Smoking Session), over an 8-hour time frame.
Primary	Cigarette Discrimination Accuracy	Participants sample 4 cigarettes of type A and 4 cigarettes of type B in a double-blind manner and indicate for each cigarette if they think it is of type A or B. Two reference trials with cigarette type unblinded will be performed before the first and fifth sample cigarette. For each sampled cigarette, the score is either 1 (correct) or 0 (incorrect). Discrimination accuracy is calculated by averaging the eight scores for each participant.	One day (in the Cigarette Discrimination Session), over a 6-hour time frame.
Secondary	Change in the number of research cigarettes smoked	In the Ad Libitum Smoking Session, participants can smoke as many research cigarettes as they wish. We quantify the number of cigarettes smoked in the first two hours and in the last two hours of the session and calculate the difference score by subtracting the number in the last two hours from that in the first two hours.	One day (in the Ad Libitum Smoking Session), over an 8-hour time frame.
Secondary	Difference in subjective state composite score	The difference in subjective state composite score is derived by transforming each subject's score on the Minnesota Nicotine Withdrawal Scale, the Affect-based Withdrawal Scale, the Questionnaire for Smoking Urges, and the modified Cigarette Evaluation Questionnaire into standard z-scores, calculating the difference between Research Cigarette A and B for each scale, and averaging the absolute values across scales.	One day (in the Cigarette Discrimination Session), over a 6-hour time frame.